Development of a Radiomics Model Using 3T Multiparametric MRI to Predict Perilesional Infiltration of Musculoskeletal Tumors During Pre-Surgery Planning for Soft Tissue Sarcoma and Bone Cancer Tumors

What this Trial Is About

Researchers are evaluating the use of radiomics, a technique analyzing MRI data, to detect tumor infiltration around suspected Bone Cancer Tumors or Soft Tissue Sarcomas (STS). The study aims to determine how accurately radiomics can identify participants truly diagnosed as positive and those who truly do not have the disease. This observational study focuses on participants suspected of these cancers who are preparing for surgical treatment. Participants will undergo MRI scans as part of their usual medical care, and their imaging data will be collected and analyzed anonymously using radiomics. The study does not add additional treatments or interventions beyond standard care. It focuses on assessing the potential clinical value of radiomics in pre-surgical planning by predicting tumor infiltration. During the study, researchers will track the positive and negative predictive values of the radiomics model from enrollment through two years of follow-up. Participants will not have additional procedures beyond their scheduled MRI scans, and their medical data will be monitored to evaluate the accuracy of this diagnostic approach. The total study participation lasts until the end of the two-year treatment period.

Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor